Report: Decline in U.S. drug development times

Total development and approval time for new drugs in the U.S. was 7.4 years for the 2007-11 period, down from 8 years in the 2002-06 period, according to a report released Wednesday by the Tufts Center for the Study of Drug Development. Most of the decline came from shortened approval times, Christopher-Paul Milne, director of research at the center told BioCentury. ...